TrialCancer prevention research (Philadelphia, Pa.)2023

Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial.

John R Davies et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.